Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.

Cite this paper

@article{Heidari2014OndansetronOP, title={Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.}, author={Mahnaz Heidari and Maryam Zarei and Seyed Mohammad Hosseini and Rheleh Taghvaei and Haleh Maleki and Mina Hajifaraj Tabrizi and Jalil Fallah and Shahin Akhondzadeh}, journal={International clinical psychopharmacology}, year={2014}, volume={29 6}, pages={344-50} }